European Journal of Pharmaceutical Sciences p. 91 - 96 (2019)
Update date:2022-08-16
Topics:
Günther, Marcel
Laux, Julian
Laufer, Stefan
The epidermal growth factor receptor (EGFR) is a well?validated drug target for the treatment of non?small cell lung cancer. Here we present an optimization approach and preliminary structure?activity relationship for 1H?pyrrolo[2,3?b]pyridines as covalent irreversible mutant EGFR inhibitors. We synthesized a focused library to investigate the effect of different aromatic substituents in the 4?position of this scaffold, interacting with the gatekeeper. We determined the activity of the synthesized compounds mutant EGFR enzyme assays and determined the selectivity over the wild type.
View MoreEvergreen Chemical Industry Ltd.
Contact:86-553-4918210
Address:6#2-602 Wanhaobailing
Tianjin Anda North Industrial & Business Co.Ltd.
Contact:86-22-24999306
Address:No.11 Erwei Road,Dongli Development Area,Tianjin,China
NINGBO YINLIANG FOREIGN TRADE CO., LTD.
Contact:+86-574-87834016 / 87898057
Address:23F NO.666JINYU ROAD,YINGZHOU DISTRICT,NINGBO.CHINA
HEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Contact:86-516-66656369
Address:The west road of Huaihai, Xuzhou, China
Doi:10.1007/s00044-016-1589-8
(2016)Doi:10.1016/j.bmcl.2014.11.088
(2015)Doi:10.1002/adsc.200505069
(2005)Doi:10.1080/10426500600977346
(2007)Doi:10.1039/c4ra08274e
(2014)Doi:10.1016/S0957-4166(01)00537-7
(2001)